Loading…

Targeting STING with cyclic di-GMP greatly augmented immune responses of glycopeptide cancer vaccines

Cyclic di-GMP (CDG) was applied to MUC1 glycopeptide-based cancer vaccines with physical mixing and built-in (at 2'-OH of CDG) strategies for activating the STING pathway. CDG in both strategies behaved as a potent immunostimulant and contributed to high titers of IgG antibodies and the express...

Full description

Saved in:
Bibliographic Details
Published in:Chemical communications (Cambridge, England) England), 2018, Vol.54 (69), p.9655-9658
Main Authors: Wu, Jun-Jun, Li, Wen-Hao, Chen, Pu-Guang, Zhang, Bo-Dou, Hu, Hong-Guo, Li, Qian-Qian, Zhao, Lang, Chen, Yong-Xiang, Zhao, Yu-Fen, Li, Yan-Mei
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cyclic di-GMP (CDG) was applied to MUC1 glycopeptide-based cancer vaccines with physical mixing and built-in (at 2'-OH of CDG) strategies for activating the STING pathway. CDG in both strategies behaved as a potent immunostimulant and contributed to high titers of IgG antibodies and the expression of multiple cytokines.
ISSN:1359-7345
1364-548X
DOI:10.1039/c8cc04860f